Baxter International Inc. company logo

# RNN 1st Gen Model Baxter International Inc. Surgical & medical instruments

Prediction models:
58.82% successful of 68 deals
$ 70.60 Last close price
at 18-may-2018

BAX

Model's trade recommendations 2.12% Return for period

-11.98% Annual return

$38.04B Market Cap

β 0.81  

BAX

Model (following trade recommendations)

BAX

Underlying stock

S&P 500

Index
Return for period 2.12%
5.09%
1.78%
52wk return -7.53%
23.40%
16.82%
52wk Range
57.15—72.26
2000.54—2399.63
Sortino ratio -1.07
Sharpe ratio -1.01
Norm. RMSE 0.77%
Downside risk 11.51%
Volatility 12.17%
  • 0.64 (0.91%) Div (Yield)
  • BUY Analysts consensus recommendation

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Baxter International Inc. (BAX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for BAX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 540M
P/E 26.99
Shares Outstanding 540M
% Held by Insiders 0.05%
% Held by Institutions 85.34%
EPS (last reported FY) $2.48
EPS (last reported Q) $0.70
EPS, estimated (last reported Q) $0.62
Total revenues $11 B
Net income $1 B